RAB3 Antibodies

RAB3 Antibodies

RAB3 antibodies are designed to detect RAB3, a member of the RAB family of small GTPases involved in regulating vesicle trafficking, particularly in synaptic vesicle exocytosis. The RAB3 subfamily includes several isoforms, such as RAB3A, RAB3B, RAB3C, and RAB3D, with RAB3A being the most extensively studied due to its prominent role in neurotransmitter release at synapses. 

Applications of RAB3 Antibodies

• Western Blotting (WB): RAB3 antibodies are used to detect RAB3 isoforms in tissue and cell lysates, particularly from brain and endocrine tissues. This application allows researchers to quantify RAB3 expression and investigate its regulation in different physiological or pathological conditions.
• Immunohistochemistry (IHC): RAB3 antibodies enable the visualization of RAB3 protein in tissue sections, especially in neuronal tissues. This technique is used to explore the spatial distribution of RAB3 in the brain, pancreas, and other secretory organs, providing insights into its role in cellular secretion and synaptic transmission.
• Immunofluorescence (IF): In immunofluorescence assays, RAB3 antibodies allow researchers to visualize the localization of RAB3 within cells, particularly at synaptic terminals and secretory vesicles. This application is crucial for studying the dynamic processes of synaptic vesicle docking and exocytosis.

RAB3 Antibodies in Disease Research

• Endocrine Disorders: RAB3 proteins, particularly RAB3D, are involved in hormone secretion from endocrine cells, including insulin secretion from pancreatic beta cells. Dysregulation of RAB3-mediated vesicle trafficking can contribute to metabolic disorders like diabetes. RAB3 antibodies are used to study vesicle secretion pathways in endocrine cells and their role in metabolic regulation.
• Cancers: RAB3 expression has been found to be dysregulated in certain cancers, where it may contribute to altered vesicle trafficking, secretion, and cellular invasion. For example, RAB3D has been implicated in breast cancer metastasis by promoting secretory pathways that support tumor cell migration and invasion. RAB3 antibodies are employed in cancer research to explore the contribution of vesicle trafficking to tumor progression.
• Neurological and Psychiatric Disorders: Abnormalities in synaptic vesicle trafficking, regulated by RAB3A, have been linked to a range of neurological and psychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. RAB3 antibodies are useful in studying synaptic dysfunction and its relationship to the pathogenesis of these disorders.

RAB3 antibodies are essential tools for investigating the regulation of synaptic vesicle exocytosis, secretory pathways, and membrane trafficking. These antibodies facilitate the study of RAB3 function in both normal physiological processes, such as neurotransmission and hormone secretion, and pathological conditions, such as neurodegenerative diseases, epilepsy, and cancer.​